Metraipolis › archive › dc_0a24497cd63b

Retrospective Analysis of Efficacy and Side Effects of Topical 4% Erythromycin Versus 1% Clindamycin Versus 20% Azelaic Acid During Pregnancy — Europe PMC PMID:40873252

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40873252
DOI
10.1111/jocd.70410
License (as archived)
solo-consultazione
Archived
2026-11-10T04:36:06.126Z
SHA-256 of the archived text
9d0325def37d29c3b910470d13217fb05ca939df89750951565d537ec668d2f0
Stable URL of this page
https://metraipolis.com/documento/dc_0a24497cd63b

How to cite

Retrospective Analysis of Efficacy and Side Effects of Topical 4% Erythromycin Versus 1% Clindamycin Versus 20% Azelaic Acid During Pregnancy — Europe PMC PMID:40873252 — Europe PMC (en), https://europepmc.org/article/MED/40873252 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0a24497cd63b (Metraipolis archive dc_0a24497cd63b, sha256 9d0325def37d29c3b910470d13217fb05ca939df89750951565d537ec668d2f0)
BibTeX
@misc{dc0a24497cd63b,
  title = {Retrospective Analysis of Efficacy and Side Effects of Topical 4% Erythromycin Versus 1% Clindamycin Versus 20% Azelaic Acid During Pregnancy — Europe PMC PMID:40873252},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40873252},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0a24497cd63b; sha256 9d0325def37d29c3b910470d13217fb05ca939df89750951565d537ec668d2f0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40873252. Agents can read the archived copy with the MCP tool read_document.